Transversus Abdominis Plane Block Versus Ilioinguinal Nerve Block for Pain Management in Inguinal Herniorraphy

NCT ID: NCT02375100

Last Updated: 2015-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares efficacy of transversus abdominis plane block and ilioinguinal nerve block for postoperative pain in patients undergoing inguinal herniorraphy with spinal anesthesia. One-third of the patients will receive standard postoperative pain regimen(control group), one-third will receive a transversus abdominis plane block (with ultrasound guidance) and the last group will receive an ilioinguinal nerve block(with ultrasound guidance) in addition to standard postoperative pain regimen. This study is a Randomized prospective open-label controlled study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intrathecal bupivacaine&analgesics

Patients will be given standard care during perioperative period. They will undergo inguinal herniorraphy operation under spinal anesthesia (with 3ml of %0.5 hyperbaric bupivacaine intrathecally) and receive an parenteral pain regimen (acetaminophen for intravenous infusion in two doses routinely and intramuscular tramadol 50 mg when pain score is higher than 4) in postoperative period.

Group Type ACTIVE_COMPARATOR

Spinal Anesthesia

Intervention Type PROCEDURE

All patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade

Bupivacaine %0.5 (hyperbaric)

Intervention Type DRUG

25G Quincke needle

Intervention Type DEVICE

Acetaminophen

Intervention Type DRUG

Analgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely

Tramadol

Intervention Type DRUG

Patients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)

TAP Block with bupivacaine

In addition to standard perioperative care (spinal anesthesia and parenteral pain regimen) patients will receive transversus abdominis plane block (with 20ml of %0.25 isobaric bupivacaine) just before surgery is initiated.

Group Type EXPERIMENTAL

Spinal Anesthesia

Intervention Type PROCEDURE

All patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade

Transversus Abdominis Plane Block

Intervention Type PROCEDURE

Analgesic intervention which will be performed only to Transversus Abdominis Plane Block arm. It requires 20ml of %0.25 bupivacaine administration through a 22 G. x 4 in. (100 mm) Insulated Echogenic Needle with 30° Bevel from midaxillary line between costal margin and anterior superior iliac spine with ultrasound guidance

Bupivacaine %0.5 (hyperbaric)

Intervention Type DRUG

Bupivacaine %0.25 (isobaric)

Intervention Type DRUG

25G Quincke needle

Intervention Type DEVICE

Echogenic Needle with 30° bevel

Intervention Type DEVICE

Acetaminophen

Intervention Type DRUG

Analgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely

Tramadol

Intervention Type DRUG

Patients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)

IlNB with bupivacaine

In addition to standard perioperative care (spinal anesthesia and parenteral pain regimen) patients will receive Ilioinguinal nerve block (with 20ml of %0.25 isobaric bupivacaine) just before surgery is initiated.

Group Type EXPERIMENTAL

Spinal Anesthesia

Intervention Type PROCEDURE

All patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade

Ilioinguinal Nerve Block

Intervention Type PROCEDURE

Analgesic intervention which will be performed only to Ilioinguinal Nerve Block arm. It requires 10ml of %0.25 bupivacaine administration through a 22 G. x 3-1/8 in. (80 mm) Insulated Echogenic Needle with 30° Bevel between umbilicus and iliac crest where the nerve is detected with ultrasound guidance

Bupivacaine %0.5 (hyperbaric)

Intervention Type DRUG

Bupivacaine %0.25 (isobaric)

Intervention Type DRUG

25G Quincke needle

Intervention Type DEVICE

Echogenic Needle with 30° bevel

Intervention Type DEVICE

Acetaminophen

Intervention Type DRUG

Analgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely

Tramadol

Intervention Type DRUG

Patients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spinal Anesthesia

All patients will be administered 3ml of %0.5 bupivacaine through L3-L4 interspace to acquire motor and sensory blockade

Intervention Type PROCEDURE

Transversus Abdominis Plane Block

Analgesic intervention which will be performed only to Transversus Abdominis Plane Block arm. It requires 20ml of %0.25 bupivacaine administration through a 22 G. x 4 in. (100 mm) Insulated Echogenic Needle with 30° Bevel from midaxillary line between costal margin and anterior superior iliac spine with ultrasound guidance

Intervention Type PROCEDURE

Ilioinguinal Nerve Block

Analgesic intervention which will be performed only to Ilioinguinal Nerve Block arm. It requires 10ml of %0.25 bupivacaine administration through a 22 G. x 3-1/8 in. (80 mm) Insulated Echogenic Needle with 30° Bevel between umbilicus and iliac crest where the nerve is detected with ultrasound guidance

Intervention Type PROCEDURE

Bupivacaine %0.5 (hyperbaric)

Intervention Type DRUG

Bupivacaine %0.25 (isobaric)

Intervention Type DRUG

25G Quincke needle

Intervention Type DEVICE

Echogenic Needle with 30° bevel

Intervention Type DEVICE

Acetaminophen

Analgesic drug administration through iv and im route postoperatively. Patients are administered iv acetaminophen 1g twice a day routinely

Intervention Type DRUG

Tramadol

Patients will be administered tramadol in postoperative period when their pain score exceeds 4 points (moderate pain)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Spinal Block TAP block IIN Block Heavy bupivacaine Plain bupivacaine Analgesics Analgesics

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients over 18 years old
* having ASA (American Society of Anesthesiologists) 1 or 2 physical status score preoperatively
* not having a neuromuscular disease
* scheduled for elective single sided inguinal herniorraphy operation

Exclusion Criteria

* being under 18 years of age
* patient refusal
* having a neuromuscular disease or sensorial neurological deficit covering similar area of effect with peripheral nerve block interventions or the surgical site
* having ASA 3 or 4 physical status score preoperatively
* having one of the contraindications to spinal anesthesia and/or to peripheral nerve blocks as listed by NYSORA (New York School of Regional Anesthesia)
* having emergency surgery or scheduled for bilateral inguinal herniorraphy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bozyaka Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Onur Okur, MD,Resident

Role: PRINCIPAL_INVESTIGATOR

Izmir Bozyaka Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Izmir Bozyaka Training and Research Hospital

Izmir, İzmir, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IzmirBoyaka

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.